Benzinga Pro’s Top 5 Stocks To Watch For Monday, Oct. 11, 2021: SOFI, PTGX, GTLB, PRPH, AVDL
Today's 5 Stock Ideas:
SoFi Technologies (SOFI) - Shares were up 4% following initiation of coverage by a Morgan Stanley analyst. The analyst set an Overweight rating (the equivalent of a buy) and a set a $25
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets amid the broader market strength.
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 4)
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned.
The Daily Biotech Pulse: AbbVie’s Migraine Drug OK’d By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 28)
Needham Initiates Coverage With Buy For This Narcolepsy Player
Needham has initiated Avadel Pharmaceuticals Plc (NASDAQ:AVDL) coverage with a Buy rating and $17 price target. Analyst Ami Fadia sees an…
Needham Initiates Coverage On Avadel Pharmaceuticals with Buy Rating, Announces Price Target of $17
Needham analyst Ami Fadia initiates coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy rating and announces Price Target of $17.
Avadel Recognizes World Narcolepsy Day And Announces New Data Presentations From Pivotal Phase 3 REST-ON Trial Of FT218 At Upcoming Conference
Avadel Pharmaceuticals plc (NASDAQ:AVDL), a company focused on transforming medicines to transform lives, today announced its support of the third annual World Narcolepsy Day on Wednesday, September 22. FT218 is the